[
  {
    "ts": null,
    "headline": "CVS Health Faces Congressional Investigation for Alleged HIPAA Violations in Louisiana Lobbying Campaign",
    "summary": "CVS Health Corporation (NYSE:CVS) is one of the best inexpensive stocks to buy according to hedge funds. On September 8, two Republican congressmen, House Oversight Committee Chair James Comer and Federal Law Enforcement Subcommittee Chair Clay Higgins, initiated an investigation into CVS on whether CVS violated the HIPAA privacy law by using confidential patient data for […]",
    "url": "https://finnhub.io/api/news?id=7cbc66b7d5bb980a6b1dac809ceb027eacd989515081f9a7cd6db42cc5ade311",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757613696,
      "headline": "CVS Health Faces Congressional Investigation for Alleged HIPAA Violations in Louisiana Lobbying Campaign",
      "id": 136704235,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health Corporation (NYSE:CVS) is one of the best inexpensive stocks to buy according to hedge funds. On September 8, two Republican congressmen, House Oversight Committee Chair James Comer and Federal Law Enforcement Subcommittee Chair Clay Higgins, initiated an investigation into CVS on whether CVS violated the HIPAA privacy law by using confidential patient data for […]",
      "url": "https://finnhub.io/api/news?id=7cbc66b7d5bb980a6b1dac809ceb027eacd989515081f9a7cd6db42cc5ade311"
    }
  },
  {
    "ts": null,
    "headline": "Danaher's Biotechnology Growth Picks Up: A Sign of More Upside?",
    "summary": "DHR's Biotechnology unit grows 6% in Q2, driven by bioprocessing, despite weakness in research equipment demand.",
    "url": "https://finnhub.io/api/news?id=c201e42a15e32c2a932c1f3b7c6077ca0793d20028a112fda48c0986f076eb04",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757609520,
      "headline": "Danaher's Biotechnology Growth Picks Up: A Sign of More Upside?",
      "id": 136704164,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "DHR's Biotechnology unit grows 6% in Q2, driven by bioprocessing, despite weakness in research equipment demand.",
      "url": "https://finnhub.io/api/news?id=c201e42a15e32c2a932c1f3b7c6077ca0793d20028a112fda48c0986f076eb04"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know",
    "summary": "CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=8a821d70b09ac5ddeab98edcf6eda0982dda0c1400ebf9573f1fb5cb8005f122",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757599204,
      "headline": "CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know",
      "id": 136704237,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=8a821d70b09ac5ddeab98edcf6eda0982dda0c1400ebf9573f1fb5cb8005f122"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Makes Headway in Stabilizing Aetna: What's Driving It?",
    "summary": "CVS makes progress in stabilizing Aetna with leadership, risk management and operational changes.",
    "url": "https://finnhub.io/api/news?id=8573aa221c9f8e081d45662701e1041a9106a00523372f6fe70b6f48432f0da6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757596920,
      "headline": "CVS Health Makes Headway in Stabilizing Aetna: What's Driving It?",
      "id": 136703899,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS makes progress in stabilizing Aetna with leadership, risk management and operational changes.",
      "url": "https://finnhub.io/api/news?id=8573aa221c9f8e081d45662701e1041a9106a00523372f6fe70b6f48432f0da6"
    }
  },
  {
    "ts": null,
    "headline": "A Fresh Look at CVS Health (CVS) Valuation Following a Year of Steady Stock Gains",
    "summary": "CVS Health Stock Draws Fresh Attention Amid Steady Gains CVS Health (CVS) is moving back into the spotlight, and this time it is not because of a headline-grabbing event. If you follow blue-chip healthcare stocks, even subtle shifts like this can raise smart questions. Investors eyeing CVS today might wonder if the latest move hints at something beneath the surface, such as changing investor expectations or just the ebb and flow of sentiment. Looking across the past year, CVS Health stock...",
    "url": "https://finnhub.io/api/news?id=a56cc68598ab28453fb49d4c1df789ef4e10d8d2764f12391862b9a395bd05e4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757595894,
      "headline": "A Fresh Look at CVS Health (CVS) Valuation Following a Year of Steady Stock Gains",
      "id": 136704239,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health Stock Draws Fresh Attention Amid Steady Gains CVS Health (CVS) is moving back into the spotlight, and this time it is not because of a headline-grabbing event. If you follow blue-chip healthcare stocks, even subtle shifts like this can raise smart questions. Investors eyeing CVS today might wonder if the latest move hints at something beneath the surface, such as changing investor expectations or just the ebb and flow of sentiment. Looking across the past year, CVS Health stock...",
      "url": "https://finnhub.io/api/news?id=a56cc68598ab28453fb49d4c1df789ef4e10d8d2764f12391862b9a395bd05e4"
    }
  }
]